PSMD1 and hematologic disorder: Altogether, our data suggest a role for PSMD1, PSMD3, and STAT3 in regulating NF-κB expression and activity in CML and TKI resistance, and implicate them as potential targets for the treatment of hematologic malignancies and possibly other forms of cancer.